Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice (Q38328379)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice (English)

1 reference

Europe PubMed Central

2 September 2017

steatohepatitis

0 references

Elizabeth M. Brunt

5

object named as

Elizabeth M Brunt

1 reference

Europe PubMed Central

2 September 2017

author name string

James L Trevaskis

1

1 reference

Europe PubMed Central

2 September 2017

Peter S Griffin

2

1 reference

Europe PubMed Central

2 September 2017

Carrie Wittmer

3

1 reference

Europe PubMed Central

2 September 2017

Brent A Neuschwander-Tetri

4

1 reference

Europe PubMed Central

2 September 2017

Carrie S Dolman

6

1 reference

Europe PubMed Central

2 September 2017

Mary R Erickson

7

1 reference

Europe PubMed Central

2 September 2017

James Napora

8

1 reference

Europe PubMed Central

2 September 2017

David G Parkes

9

1 reference

Europe PubMed Central

2 September 2017

Jonathan D Roth

10

1 reference

Europe PubMed Central

2 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 January 2012

1 reference

Europe PubMed Central

2 September 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 reference

Europe PubMed Central

2 September 2017

302

1 reference

Europe PubMed Central

2 September 2017

8

1 reference

Europe PubMed Central

2 September 2017

G762-72

1 reference

Europe PubMed Central

2 September 2017

Epidemiology and natural history of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Biological activity of AC3174, a peptide analog of exendin-4.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Animal models of NASH: getting both pathology and metabolic context right

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

The epidemiology of nonalcoholic fatty liver disease: a global perspective

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effect of weight reduction on hepatic abnormalities in overweight patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effects of weight loss on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Incretin mimetics as a novel therapeutic option for hepatic steatosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Identifiers

10.1152/AJPGI.00476.2011

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38328379&oldid=1753698118"